Level of selective serotonin reuptake inhibitor-related sexual dysfunction in men and women

Burhan, Huseyin Sehit; Kuru, Tacettin

doi:10.14744/DAJPNS.2022.00199

Huseyin Sehit Burhan¹ ,

Tacettin Kuru²

¹Basaksehir Cam and Sakura City Hospital, Department of Psychiatry, Istanbul, Turkiye
²Alanya Alaaddin Keykubat University, Training and Research Hospital, Department of Psychiatry, Antalya, Turkiye

Dusunen Adam Journal of Psychiatry and Neurological Sciences 2022; 35(4): 247-253 DOI: 10.14744/DAJPNS.2022.00199

Full Text PDF

Abstract

Objective: Up to 80% of selective serotonin reuptake inhibitor (SSRI) users experience a kind of sexual dysfunction related to antidepressant treatment, which may cause discontinuation of the medication. This study aims to determine the level of reported sexual dysfunction of SSRI users and evaluate factors related to sexual dysfunction.
Method: Sexual dysfunction, demographic variables, and depression level of 40 men and 40 women were evaluated by demographic data form, Beck Depression Inventory, and Psychotropic-Related Sexual Dysfunction Questionnaire.
Results: According to the results of this study, there was no significant difference in the level of psychotropic-related sexual dysfunction for genders and marital status (p>0.05). There was no correlation level of sexual dysfunction and age or depression levels (p>0.05).
Conclusion: Both men and women (young or older and single or married) may experience sexual dysfunction related SSRIs. All SSRI users should be questioned and monitored for sexual dysfunction.

Keywords: Depression, selective serotonin reuptake inhibitors, sexual dysfunctions